To access this element change to forms mode OFF
Grant Award View - GA204238
ComBATing lethal prostate cancer with combination Bipolar Androgen...
GA ID:
GA204238
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
6-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$952,194.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
ComBATing lethal prostate cancer with combination Bipolar Androgen Therapy
Purpose:
For 80 years, the main way to treat advanced prostate cancer has been to cut off the supply of male hormones. Unfortunately, this only works temporarily and it compromises quality of life. Surprisingly, new clinical trials show that the opposite approach – supplying excess testosterone – is effective and improves quality of life. Our novel idea is to boost the efficacy of testosterone therapy, and ensure more patients benefit, by combining it with a second drug.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011033
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA